23 research outputs found
Safety of Use of Russian Biosimilars of Interferon Beta-1b in the Treatment of Multiple Sclerosis: a Meta-analysis of Original Studies
Presently, an active search for modern drugs for the treatment of multiple sclerosis is ongoing. Since the treatment with original drugs is expensive, therefore, the development of local biosimilars is underway, which at a lower cost should be effective and safe as original ones. The aim of the study is to compare the safety of foreign preparations of interferon beta-1b (Betaferon and Ekstavia) with Russian biosimilars (Ronbetal®, Infibeta®) in the treatment of multiple sclerosis to ensure the possibility of import substitution. In the present study the safety of domestic interferon beta-1b biosimilars in the treatment of multiple sclerosis was studied using a meta-analysis method. There were 3 studies included in the meta-analysis. A total of 778 people participated in the study. The average age of the subjects was 35.92 ± 9.57 years. The main inclusion criteria were a reliable diagnosis of remittent or secondary progressive multiple sclerosis with exacerbations, an EDSS score less than 5.5. The subjects were divided into 2 groups: the first group received therapy with the Russian biosimilars of interferon beta-1b (Ronbetal®, Infibeta®), the second — the foreign ones (Betaferon, Extavia) in therapeutic doses. The duration of therapy was at least 6 weeks. Results. A meta-analysis of three studies showed the following data: the difference in the frequency of local complications such as hyperemia in patients who received Russian and foreign interferon beta-1b analogues statistically insignificant, the relative risk is 1.243 (p > 0.05). No statistically significant differences in the frequency of influenza-like syndrome were also detected: the relative risk is 1.459 (p > 0.05). Conclusion. This study has increased the power of the evidence base in the application of Russian biosimilars. The conducted meta-analysis showed the absence of a statistically significant difference in the incidence of such side effects as the injection site hyperemia and the influenza-like syndrome in domestic biosimilars of interferon beta-1b compared with foreign ones
Energy & Fuels
This study investigates the formation and characteristics of reaction intermediates from the fast pyrolysis of NaCl and MgCl2-loaded celluloses (75-106 µm) at 150-400 °C. The loading of MgCl2 lowers the onset temperature of cellulose pyrolysis. At low temperatures (e.g., 150 °C), the loading of MgCl2 increases the yield of water-soluble intermediates and significantly enhances the formation of sugar and anhydro-sugar oligomers. However, the effect of NaCl loading is minimal under the similar conditions. The results suggest that the loading of MgCl2 catalyzes the cleavage of both hydrogen bonds and glycosidic bonds during cellulose pyrolysis at low temperatures. At increased temperatures (250 °C and above), both the loading of NaCl and the loading of MgCl2 greatly enhance the destruction of sugar ring structures within the pyrolyzing cellulose. The conversion of water-insoluble solid into water-soluble intermediates, which are important precursors for volatile formation, is reduced significantly, leading to an increase in char yield